Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Hims & Hers Health Inc
(NY:
HIMS
)
14.73
+0.09 (+0.61%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Hims & Hers Health Inc
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Why Hims & Hers Health Stock Was Falling This Week
Today 21:52 EDT
A new threat from Eli Lilly pushed the stock lower.
Via
The Motley Fool
Is Hims & Hers Health Stock a Buy?
Today 4:30 EDT
The stock has been a strong performer this year, but the best could be yet to come.
Via
The Motley Fool
Why Hims & Hers Stock Crashed on Tuesday
August 27, 2024
Could a competitor lowering prices eat into Hims & Hers market share?
Via
The Motley Fool
Why Hims & Hers Health Stock Is Falling
August 27, 2024
Eli Lilly's launch of the competitively priced Zepbound has triggered a 4.9% drop in Hims & Hers' stock. This has raised concerns over increased competition and potential market share loss.
Via
Benzinga
American Woodmark Reports Downbeat Results, Joins Snowflake And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
August 27, 2024
Via
Benzinga
Eli Lilly Halves Zepbound Price In New Version Of Weight-Loss Drug
August 27, 2024
The single-dose vials will also increase supply, the drug giant says.
Via
Investor's Business Daily
What Is Going On With Hims & Hers Stock?
August 22, 2024
After a strong start to the year, the stock is down 30% since June.
Via
The Motley Fool
The Latest Analyst Ratings For Hims & Hers Health
August 22, 2024
Via
Benzinga
Looking Into Hims & Hers Health's Recent Short Interest
August 19, 2024
Via
Benzinga
Hims & Hers Health Sees Major Growth Opportunity In Booming Weight Loss Market, Says Analyst
August 22, 2024
Needham analyst initiates coverage on Hims & Hers Health, Inc. with a Buy rating and $24 price target. Anticipates positive impact from GLP-1 market entry and strong growth potential.
Via
Benzinga
Telehealth Firm Hims & Hers Health Rides High On Demand for Copycat Weight Loss Drugs Amid Supply Shortages
August 19, 2024
Hims & Hers Health has seen its stock rise over 120% due to soaring demand for its affordable compounded GLP-1 weight-loss drugs, despite legal battles and safety concerns surrounding its...
Via
Benzinga
2 Magnificent Stocks That Are Screaming Buys in August
August 19, 2024
These companies aren't slowing down.
Via
The Motley Fool
Is Hims & Hers Health the Best Growth Stock for You?
August 16, 2024
Wall Street is missing the forest for the trees, and the opportunity is enormous.
Via
The Motley Fool
Prediction: Up 74% So Far This Year, This Weight Loss Stock Is About to Crater
August 16, 2024
A small telemedicine company just entered the weight loss race.
Via
The Motley Fool
Hims & Hers Health Unusual Options Activity For August 13
August 13, 2024
Via
Benzinga
Analyst Expectations For Hims & Hers Health's Future
August 06, 2024
Via
Benzinga
How Is The Market Feeling About Hims & Hers Health?
July 26, 2024
Via
Benzinga
This 1 Piece of Good News for Eli Lilly Is Bad News for Hims & Hers Health Stock
August 13, 2024
A company's investments can easily ruin the plans of its competitors.
Via
The Motley Fool
Hims & Hers Health Boosts Outlook. Is This a Golden Opportunity to Buy the Stock?
August 11, 2024
Growth is set to accelerate starting next quarter, powered by its GLP-1 offering.
Via
The Motley Fool
Hims & Hers Stock Crashed but This Is a Growth Machine
August 07, 2024
Don't overlook the 52% growth in the second quarter.
Via
The Motley Fool
HIMS Stock Earnings: Hims & Hers Health Beats EPS, Beats Revenue for Q2 2024
August 05, 2024
HIMS stock results show that Hims & Hers Health beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Hims & Hers Health Reports Better-Than-Expected Q2 Results: Details
August 05, 2024
Hims & Hers Health reported its second-quarter financial results Monday. Here's a look at the details from the report.
Via
Benzinga
3 Telemedicine Stocks Poised for Possible Healthcare Evolution
August 05, 2024
Once the pandemic ended, so did the massive run in telemedicine stocks. However, there's still reason to buy.
Via
InvestorPlace
Hims & Hers Stock Is Looking to Cash in From the GLP-1 Hype, but Will Its Controversial Strategy Pay Off?
August 02, 2024
Hims & Hers stock has been surging since May, but has its valuation gotten too rich?
Via
The Motley Fool
What's Going On With HIMS Shares Today?
August 01, 2024
Hims & Hers Health experienced a significant decline in its stock price on Thursday. Here's what you need to know.
Via
Benzinga
Got $200? 2 Best Growth Stocks to Buy and Hold Forever
August 01, 2024
Even a modest investment can help you start a position in quality stocks.
Via
The Motley Fool
Marker Rotation Is In Full Gear
July 28, 2024
We saw more new 52-week highs, and the number of 52-week lows was even lower than last week. The advance/decline in the NYSE looks better than the Nasdaq.
Via
Talk Markets
ViaSat & AST SpaceMobile Are Among Top 6 Mid Cap Stocks That Shined The Brightest Last Week (July 21-July 27): Are The Others In Your Portfolio?
July 28, 2024
Top mid-cap stocks of the week: ASTS up 47.88%, GSHD up 39.86%, VSAT up 30.78%, VKTX up 29.86%, BEAM up 23.93%, CLDX up 19.72%
Via
Benzinga
3 Game-Changing Stocks on the Edge of Unprecedented Gains
July 25, 2024
These three game-changing stocks appear ready to shift the valuation landscape and provide investors with outstanding returns.
Via
InvestorPlace
3 Once-in-a-Lifetime Stock Opportunities You Can’t Miss: July 2024
July 24, 2024
Discover three high-potential stocks in the tech, financial and healthcare sectors that can deliver significant returns.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.